Cannabotech Ltd. Logo

Cannabotech Ltd.

Develops botanical medical solutions from cannabinoids & mushrooms for healthcare and wellness.

CNTC | TA

Overview

Corporate Details

ISIN(s):
IL0011769085
LEI:
Country:
Israel
Address:
3 Arik Einstein, 4659071 Herzliya
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cannabotech Ltd. is a biomedical company focused on the research, development, and commercialization of botanical medical solutions. The company's core strategy involves integrating the therapeutic properties of cannabinoids and functional mushrooms to create innovative healthcare products. Its pipeline includes preventative care solutions and treatments targeting various indications such as cancer, chronic pain, and inflammation. Cannabotech also develops personalized cannabinoid-based formulas, CBD-infused food supplements, and skincare products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-10 17:47
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2025-01-09 10:41
Regulatory News Service
Capital consolidation 10:1, There will be no trading in the company's shares on…
Hebrew (modern) 77.6 KB
2024-11-12 18:33
Regulatory News Service
Trading in the company's shares (ISIN IL0011769085) will be renewed on Thursday…
Hebrew (modern) 158.8 KB
2024-10-01 10:13
Regulatory News Service
Suspension due to failure in publication of financial reports
Hebrew (modern) 79.6 KB
2024-09-29 17:58
Regulatory News Service
CANNABOTECH– Appointment of a Market Maker
Hebrew (modern) 151.8 KB
2024-09-23 19:44
Regulatory News Service
Failure in publishing financial reports-Notification
Hebrew (modern) 127.4 KB
2024-09-02 15:06
Regulatory News Service
Discontinuation of Market Making
Hebrew (modern) 92.1 KB
2022-01-11 15:43
Regulatory News Service
Opening of Trading on January 12 2022- CANNABOTECH W3
Hebrew (modern) 253.5 KB
2022-01-10 10:54
Regulatory News Service
Identifying Details of New Security-CANNABOTECH W3
Hebrew (modern) 174.6 KB
2021-09-13 19:45
Regulatory News Service
will not be added TA-Tech Elite Index
Hebrew (modern) 82.9 KB
2021-07-25 18:17
Regulatory News Service
Fast Track to TA-Tech Elite Index as on October 7th, 2021 at the end of the tra…
Hebrew (modern) 162.5 KB
2021-07-25 16:07
Regulatory News Service
Appointment of a Market Maker
Hebrew (modern) 210.0 KB
2021-07-21 18:34
Regulatory News Service
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 244.6 KB
2021-06-15 16:11
Regulatory News Service
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 155.0 KB

Automate Your Workflow. Get a real-time feed of all Cannabotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cannabotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.